Epidémiologie, stratégies thérapeutiques et virologie cliniques dans l'infection à VIH
Accueil
FHDH
A propos de la base
Déjà 20 ans !
DOMEVIH
Principaux résultats
- RICE février 2013
- Publications
L'équipe
- Le GEC
- U1136 (ex-U943)
Collaborations
Etudes cliniques
ONCOVIH
Autres études
EPIDERMAS
FranceCoag
Doctorants - post-docs
EPICLIN 2010

Liste des publications à partir des données
de la base FHDH

2012 2011 2010
2005-2009 2000-2004 1992-1999

2000       12  
Bernillon P, Lievre L, Pillonel J, Laporte A, Costagliola D.
-->  Record-linkage between two anonymous databases for a capture-recapture estimation of underreporting of AIDS cases: France 1990-1993.
---->  Int J Epidemiol. 2000 Feb;29(1):168-74.
        13  
Grabar S, Le Moing V, Goujard C, Leport C, Kazatchkine MD, Costagliola D, Weiss L.
-->  Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.
---->  Ann Intern Med. 2000 Sep 19;133(6):401-10.
Comment in:
Ann Intern Med. 2000 Sep 19;133(6):471-3.
        14  
Grabar S, Pradier C, Le Corfec E, Lancar R, Allavena C, Bentata M, Berlureau P, Dupont C, Fabbro-Peray P, Poizot-Martin I, Costagliola D.
-->  Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor.
---->  AIDS. 2000 Jan 28;14(2):141-9.
        15  
Mary-Krause M, Rabaud C, Jouan M, Obadia M, de la Blanchardiere A, Raffi F, May T.
-->  Mycobacterium avium complex disease in HIV seropositive patients: incidence and risk factors before and after the introduction of highly active antiretroviral treatments. [Article in French]
---->  Pathol Biol (Paris). 2000 Jun;48(5):495-504.
2001       16  
Abgrall S, Matheron S, Le Moing V, Dupont C, Costagliola D; Clinical Epidemiology Group from the French Hospital Database on HIV.
-->  Pneumocystis carinii pneumonia recurrence in HIV patients on highly active antiretroviral therapy: secondary prophylaxis.
---->  J Acquir Immune Defic Syndr. 2001 Feb 1;26(2):151-8.
        17  
Abgrall S, Rabaud C, Costagliola D; Clinical Epidemiology Group of the French Hospital Database on HIV.
-->  Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era.
---->  Clin Infect Dis. 2001 Nov 15;33(10):1747-55. Epub 2001 Oct 10. Comment in:
Clin Infect Dis. 2002 Apr 15;34(8):1161.
        18  
Besson C, Goubar A, Gabarre J, Rozenbaum W, Pialoux G, Chatelet FP, Katlama C, Charlotte F, Dupont B, Brousse N, Huerre M, Mikol J, Camparo P, Mokhtari K, Tulliez M, Salmon-Ceron D, Boue F, Costagliola D, Raphael M.
-->  Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy.
---->  Blood. 2001 Oct 15;98(8):2339-44
2002       19  
Del Giudice P, Mary-Krause M, Pradier C, Grabar S, Dellamonica P, Marty P, Gastaut JA, Costagliola D, Rosenthal E; French Hospital Database on HIV Clinical Epidemiologic Group.
-->  Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus.
---->  J Infect Dis. 2002 Nov 1;186(9):1366-70. Epub 2002 Oct 11.
        20  
Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F, Costagliola D, D'Arminio Monforte A, de Wolf F, Reiss P, Lundgren JD, Justice AC, Staszewski S, Leport C, Hogg RS, Sabin CA, Gill MJ, Salzberger B, Sterne JA; ART Cohort Collaboration.
-->  Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
---->  Lancet. 2002 Jul 13;360(9327):119-29.
Erratum in:
Lancet 2002 Oct 12;360(9340):1178.
        21  
Tassie JM, Grabar S, Lancar R, Deloumeaux J, Bentata M, Costagliola D; Clinical Epidemiology Group from the French Hospital Database on HIV.
-->  Time to AIDS from 1992 to 1999 in HIV-1-infected subjects with known date of infection.
---->  J Acquir Immune Defic Syndr. 2002 May 1;30(1):81-7.
2003       22  
Abgrall S, Duval X, Joly V, Descamps D, Matheron S, Costagliola D; The Clinical Epidemiology Group from the French Hospital Database on HIV.
-->  Clinical and immunologic outcome in patients with Human Immunodeficiency Virus Infection, according to virologic efficacy in the year after virus undetectability, during antiretroviral therapy.
---->  Clin Infect Dis. 2003 Dec 1;37(11):1517-26. Epub 2003 Oct 29.
        23  
Chene G, Sterne JA, May M, Costagliola D, Ledergerber B, Phillips AN, Dabis F, Lundgren J, D'Arminio Monforte A, de Wolf F, Hogg R, Reiss P, Justice A, Leport C, Staszewski S, Gill J, Fatkenheuer G, Egger ME; Antiretroviral Therapy Cohort Collaboration.
-->  Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies.
---->  Lancet. 2003 Aug 30;362(9385):679-86.
        24  
Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C, Plaisance N, Tissot-Dupont H, Boue F, Lang JM, Costagliola D.
-->  Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.
---->  J Clin Oncol. 2003 Sep 15;21(18):3447-53.
        25  
Kousignian I, Abgrall S, Duval X, Descamps D, Matheron S, Costagliola D; Clinical Epidemiology Group of the French Hospital Database on HIV.
-->  Modeling the time course of CD4 T-lymphocyte counts according to the level of virologic rebound in HIV-1-infected patients on highly active antiretroviral therapy.
---->  J Acquir Immune Defic Syndr. 2003 Sep 1;34(1):50-7.
        26  
Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D; And the Clinical Epidemiology Group from the French Hospital Database.
-->  Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.
---->  AIDS. 2003 Nov 21;17(17):2479-86.
2004       27  
Grabar S, Kousignian I, Sobel A, Le Bras P, Gasnault J, Enel P, Jung C, Mahamat A, Lang JM, Costagliola D.
-->  Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV.
---->  AIDS. 2004 Oct 21;18(15):2029-38.
        28  
Mary-Krause M, Herida M, Costagliola D, Lavole A, Cadranel J.
-->  In reply.
---->  J Clin Oncol. 2004 Apr 1;22(7):1349-50.
        29  
May M, Royston P, Egger M, Justice AC, Sterne JAC and the ART Cohort Collaboration.
-->  Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy.
---->  Statistics in Medicine 2004; 23: 2375-98.
        30  
Phillips A, Ledergerber B, Lundgren J, Hogg B, D'Arminio Monforte A, Castelli F, Walker S, Staszewski S, Dabis F, Gazzard B, Saag M, Petoumenos K, Johnson M, Scullard G, Gill J, James I, Fischer M, Mussini C, Klein M, Costagliola D for the Collaboration of HIV Cohorts. 
-->  Nucleoside analogue use before and during highly active antiretroviral therapy and virus load rebound.
---->  J Infect Dis. 2004 Aug 15;190(4):675-87.
Adresse Mentions légales Extranet Administration